INS and diabetes mellitus: With respect to iPSC-derived skeletal muscle cell use in the setting of diabetes, Wang and colleagues reported that an increased rate of myoblast serial passaging decreases their proliferation rate, increases DNA damage, and reduces their sensitivity to insulin [77] with reduced insulin responsiveness to glucose uptake, glycogen synthesis, and lipid metabolism.